Table II.
Diagnosis | Patients, n | Male, n (%) | Female, n (%) |
---|---|---|---|
ET | 80 | 32 (40.0) | 48 (60.0) |
PV | 39 | 20 (51.3) | 19 (48.7) |
PMF | 14 | 9 (64.3) | 5 (35.7) |
ET, essential thrombocythaemia; PV, polycythaemia vera; PMF, primary myelofibrosis.
Diagnosis | Patients, n | Male, n (%) | Female, n (%) |
---|---|---|---|
ET | 80 | 32 (40.0) | 48 (60.0) |
PV | 39 | 20 (51.3) | 19 (48.7) |
PMF | 14 | 9 (64.3) | 5 (35.7) |
ET, essential thrombocythaemia; PV, polycythaemia vera; PMF, primary myelofibrosis.